69 Results

People

  1. Moskowitz
    Moskowitz
  2. Zelenetz
    Zelenetz
  3. Portlock
    Portlock
  4. Noy
    Noy
  5. Yahalom
    Yahalom
  6. Hamlin
    Hamlin
  7. Matasar
    Matasar
  8. Straus
    Straus
  9. Horwitz
    Horwitz
  10. Nimer
    Nimer

Groups

  1. Department of Medicine (69)
  2. Hematologic Malignancies, Division of (69)
  3. Center for Hematologic Malignancies (61)
  4. Lymphoma (59)
  5. Survivorship Research (34)
  6. Epidemiology and Biostatistics (27)
  7. Biostatistics Service (25)
  8. Radiation Oncology, Department of (21)
  9. Nursing (18)
  10. Population Sciences Research Program (18)
  1. "aged"
  2. "Craig Moskowitz"
Formats
  1. Journal Article (68)
  2. Research Letter (1)
Groups
  1. Department of Medicine (69)
  2. Hematologic Malignancies, Division of (69)
  3. Center for Hematologic Malignancies (61)
  4. Lymphoma (59)
  5. Survivorship Research (34)
  6. Epidemiology and Biostatistics (27)

More Groups

People
  1. Craig Moskowitz (69)
  2. Andrew Zelenetz (54)
  3. Carol Portlock (30)
  4. David Straus (30)
  5. Paul Hamlin (28)
  6. Ariela Noy (25)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (1)
  6. 2018 (2)

More Years

Publications
  1. Blood (12)
  2. Journal of Clinical Oncology (12)
  3. British Journal of Haematology (11)
  4. Annals of Oncology (5)
  5. Leukemia and Lymphoma (5)
  6. Biology of Blood and Marrow Transplantation (4)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. American Society of Clinical Oncology (12)
  3. John Wiley & Sons (11)
  4. Elsevier Inc. (6)
  5. Nature Publishing Group (5)
  6. Oxford University Press (5)

More Publishers

Results (69)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with CREBBP or EP300 mutations: An open label phase II study
    Research Letter

    Qualls, D.; Noy, A.; Straus, D.; Matasar, M.; Moskowitz, C.; Seshan, V.; Dogan, A.; Salles, G.; Younes, A.; Zelenetz, A. D.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: A phase II risk-adapted design
    Journal Article

    Kumar, A.; Casulo, C.; Joffe, E.; Moskowitz, C.; Gerecitano, J.; Moskowitz, A.; Younes, A.; Drullinsky, P.; Drill, E.; Choma, M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma
    Journal Article

    Lin, R. J.; Owens, C. N.; Drill, E.; Iannotta, A.; Oliveros, M.; Schick, D. L.; Noy, A.; Gerecitano, J. F.; Drullinsky, P. R.; Caron, P. C.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Phase I/Ib study of the efficacy and safety of buparlisib and ibrutinib therapy in MCL, FL, and DLBCL with serial cell-free DNA monitoring
    Journal Article

    Stewart, C. M.; Michaud, L.; Whiting, K.; Nakajima, R.; Nichols, C.; De Frank, S.; Hamlin, P. A. Jr; Matasar, M. J.; Gerecitano, J. F.; Drullinsky, P.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Involved-site radiotherapy for Helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patients
    Journal Article

    Yahalom, J.; Xu, A. J.; Noy, A.; Lobaugh, S.; Chelius, M.; Chau, K.; Portlock, C.; Hajj, C.; Imber, B. S.; Straus, D. J.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Noninvasive monitoring of mantle cell lymphoma by immunoglobulin gene next-generation sequencing in a phase 2 study of sequential chemoradioimmunotherapy followed by autologous stem-cell rescue
    Journal Article

    Kumar, A.; Bantilan, K. S.; Jacob, A. P.; Park, A.; Schoninger, S. F.; Sauter, C.; Ulaner, G. A.; Casulo, C.; Faham, M.; Kong, K. A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Follicular lymphoma in the modern era: Survival, treatment outcomes, and identification of high-risk subgroups
    Journal Article

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Caron, P. C.; Falchi, L.; Hamilton, A.; more...
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma
    Journal Article

    von Tresckow, B.; Fanale, M.; Ardeshna, K. M.; Chen, R.; Meissner, J.; Morschhauser, F.; Moskowitz, C.; Zinzani, P. L.; Giezek, H.; Balakumaran, A.; more...
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save
  • Outcomes of relapsed and refractory primary mediastinal (thymic) large B cell lymphoma treated with second-line therapy and intent to transplant
    Journal Article

    Vardhana, S.; Hamlin, P. A.; Yang, J.; Zelenetz, A.; Sauter, C. S.; Matasar, M. J.; Ni, A.; Yahalom, J.; Moskowitz, C. H.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL
    Journal Article

    Sauter, C. S.; Matasar, M. J.; Schoder, H.; Devlin, S. M.; Drullinsky, P.; Gerecitano, J.; Kumar, A.; Noy, A.; Palomba, M. L.; Portlock, C. S.; more...
    Blood (2018)

    Fulltext@MSK | Save